Teva Pursues First Type 1 Diabetes Treatment Since Insulin

Teva Pharmaceutical, the world’s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment to succeed insulin for Type 1 diabetes.
Bloomberg